WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Honasa Consumer to acquire 58% stake in Fluence Pharma

In a BSE filing, the company said it will acquire a majority stake via secondary purchase at about ₹135 crores enterprise value and will acquire the remaining 42% in two tranches over the next 5-7 years

Raccontata daeconomictimes.indiatimes.comthehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
thehindubusinessline.comStai leggendo2 g fa

Honasa Consumer to acquire 58% stake in Fluence Pharma

In a BSE filing, the company said it will acquire a majority stake via secondary purchase at about ₹135 crores enterprise value and will acquire the remaining 42% in two tranches over the next 5-7 years

originale
economictimes.indiatimes.com2 g fa

Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value

Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition in under a year, signals a growing trend…

Leggi questa versione → originale

Timeline cronologica

  1. martedì 23 giugno 2026·economictimes.indiatimes.com

    Honasa Consumer to acquire majority stake in hair therapy brand Fluence Pharma at Rs 135-crore valuation - The Economic Times

    Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's second acquisition in under a year,…

  2. martedì 23 giugno 2026·economictimes.indiatimes.com

    Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence Pharma

    Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry into the health and wellness supplements…

  3. martedì 23 giugno 2026·economictimes.indiatimes.com

    Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value

    Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition…

  4. mercoledì 24 giugno 2026·thehindubusinessline.com

    Honasa Consumer to acquire 58% stake in Fluence Pharma

    In a BSE filing, the company said it will acquire a majority stake via secondary purchase at about ₹135 crores enterprise value and will acquire the remaining 42% in two tranches…

  5. mercoledì 24 giugno 2026·thehindubusinessline.com

    Honasa shares slip 3% after it announces acquisition of nutraceuticals maker Fluence Pharma

    Honasa shares drop 3% after announcing acquisition of Fluence Pharma, despite initial gains and positive long-term market outlook.